189 related articles for article (PubMed ID: 32383189)
41. COVID-19 pandemic.
Moock M; Mello PMVC
Rev Bras Ter Intensiva; 2020 Mar; 32(1):1. PubMed ID: 32401986
[No Abstract] [Full Text] [Related]
42. [Dermatological manifestations of COVID-19].
Jouret G; Damsin T; Vanhakendover L; Bailleux S; Braham C; Nikkels AF
Rev Med Liege; 2020 Sup; 75(S1):115-118. PubMed ID: 33211432
[TBL] [Abstract][Full Text] [Related]
43. Case Report: Chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window?
Ludzik J; Witkowski A; Hansel DE; Raess PW; White K; Leachman S
F1000Res; 2020; 9():668. PubMed ID: 32913640
[TBL] [Abstract][Full Text] [Related]
44. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
[TBL] [Abstract][Full Text] [Related]
45. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
Yatim A; Gilliet M
Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
[TBL] [Abstract][Full Text] [Related]
46. Pediatric COVID toes and fingers.
Koschitzky M; Oyola RR; Lee-Wong M; Abittan B; Silverberg N
Clin Dermatol; 2021; 39(1):84-91. PubMed ID: 33972057
[TBL] [Abstract][Full Text] [Related]
47. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
[TBL] [Abstract][Full Text] [Related]
48. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
[TBL] [Abstract][Full Text] [Related]
49. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
Fertitta L; Welfringer-Morin A; Ouedrani A; Polivka L; Chhun S; Chatenoud L; Fourgeaud J; Hadj-Rabia S; Temmam S; Eloit M; Sermet-Gaudelus I; Bodemer C
J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e164-e167. PubMed ID: 33010072
[No Abstract] [Full Text] [Related]
50. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
[TBL] [Abstract][Full Text] [Related]
51. Negative SARS-CoV-2 PCR in patients with chilblain-like lesions.
Hubiche T; Le Duff F; Chiaverini C; Giordanengo V; Passeron T
Lancet Infect Dis; 2021 Mar; 21(3):315-316. PubMed ID: 32563281
[No Abstract] [Full Text] [Related]
52. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
[TBL] [Abstract][Full Text] [Related]
53. Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
De Greef A; Choteau M; Herman A; Bouzin C; Marot L; Dachelet C; Lelotte J; Hoton D; Dumoutier L; Baeck M
Eur J Dermatol; 2022 May; 32(3):377-383. PubMed ID: 36065533
[TBL] [Abstract][Full Text] [Related]
54. Chilblains-like Nonischemic Eruption During the COVID-19 Pandemic-Distinct Features in Adolescents.
Gorouhi F
JAMA Netw Open; 2021 Jun; 4(6):e2111676. PubMed ID: 34110397
[No Abstract] [Full Text] [Related]
55. Suspected COVID-19-related reticulated purpura of the soles in an infant.
Andina D; Colmenero I; Santonja C; Muñoz de León I; Noguera-Morel L; Hernández-Martín A; Torrelo A
Pediatr Dermatol; 2021 Jan; 38(1):301-303. PubMed ID: 33085141
[TBL] [Abstract][Full Text] [Related]
56. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
[TBL] [Abstract][Full Text] [Related]
57. Detection of a second outbreak of chilblain-like lesions during COVID-19 pandemic through teledermatology.
Giraud-Kerleroux L; Mongereau M; Cassius C; Mrad M; Gary C; Fiani C; Ben Kahla M; Mahevas T; Zuelgaray E; Skayem C; Hua C; Ezzedine K; Bagot M; Bouaziz JD; Duong TA
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e556-e558. PubMed ID: 34014574
[No Abstract] [Full Text] [Related]
58. Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic".
López-Sundh AE; Gómez-Fernández C; González-López MA
J Cutan Med Surg; 2021; 25(3):342-343. PubMed ID: 33624512
[No Abstract] [Full Text] [Related]
59. Contemporary occurrence of Chilblain-like lesions and Pityriasis rosea during the COVID-19 pandemic.
Piccolo V; Bassi A; Argenziano G; Mazzatenta C; Cutrone M; Neri I; Grimalt R; Russo T
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e619-e620. PubMed ID: 34050995
[No Abstract] [Full Text] [Related]
60. Relapse of chilblain-like lesions during the second wave of the COVID-19 pandemic: a cohort follow-up.
Hubiche T; Le Duff F; Fontas E; Rapp J; Chiaverini C; Passeron T
Br J Dermatol; 2021 Oct; 185(4):858-859. PubMed ID: 34128539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
